SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter E. Thorpe who wrote (1281)3/20/1998 6:47:00 PM
From: D.Right  Read Replies (2) of 2173
 
Dear Peter:

Everything is riding on the up-coming European trials. I like the chance a lot (please see my post #1274 from last week). The Motley's column didn't say anything new because there is nothing new developed since last Aug. other than JNJ changed its mind. Because it is JNJ, with JNJ's reputation, AMLN can only get investors confidence back with facts --- the trial data. Anything else won't help in the short term. (unless they find another big pharm who likes their chances, too)

Good luck.

D.Right
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News